Share

Eli Lilly begins phase 3 trial for Covid-19 treatment

Eli Lilly says it's beginning a phase 3 clinical trial for its drug baricitinib for patients who are hospitalized for Covid-19. CNBC's Joe Kernen reports.
01:05
Thu, Jun 18 20208:35 AM EDT